ATE238342T1 - Neue thrombin-inhibitoren, deren herstellung und verwendung - Google Patents

Neue thrombin-inhibitoren, deren herstellung und verwendung

Info

Publication number
ATE238342T1
ATE238342T1 AT96922355T AT96922355T ATE238342T1 AT E238342 T1 ATE238342 T1 AT E238342T1 AT 96922355 T AT96922355 T AT 96922355T AT 96922355 T AT96922355 T AT 96922355T AT E238342 T1 ATE238342 T1 AT E238342T1
Authority
AT
Austria
Prior art keywords
preparation
thrombin inhibitors
new thrombin
new
inhibitors
Prior art date
Application number
AT96922355T
Other languages
English (en)
Inventor
David Gustafsson
Jan-Erik Nystroem
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9502487A external-priority patent/SE9502487D0/xx
Priority claimed from SE9502505A external-priority patent/SE9502505D0/xx
Priority claimed from SE9502504A external-priority patent/SE9502504D0/xx
Priority claimed from SE9503923A external-priority patent/SE9503923D0/xx
Priority claimed from SE9504349A external-priority patent/SE9504349D0/xx
Priority claimed from GBGB9526411.5A external-priority patent/GB9526411D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE238342T1 publication Critical patent/ATE238342T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
AT96922355T 1995-07-06 1996-07-02 Neue thrombin-inhibitoren, deren herstellung und verwendung ATE238342T1 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
SE9502487A SE9502487D0 (sv) 1995-07-06 1995-07-06 New amino acid derivatives
SE9502505A SE9502505D0 (sv) 1995-07-07 1995-07-07 New amino acid derivatives
SE9502504A SE9502504D0 (sv) 1995-07-07 1995-07-07 New amino acid derivatives
SE9503923A SE9503923D0 (sv) 1995-11-07 1995-11-07 New amino acid derivatives
SE9504349A SE9504349D0 (sv) 1995-12-05 1995-12-05 New amino acid derivatives
GBGB9526411.5A GB9526411D0 (en) 1995-12-22 1995-12-22 Compounds
PCT/SE1996/000878 WO1997002284A1 (en) 1995-07-06 1996-07-02 New thrombin inhibitors, their preparation and use

Publications (1)

Publication Number Publication Date
ATE238342T1 true ATE238342T1 (de) 2003-05-15

Family

ID=27547251

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96922355T ATE238342T1 (de) 1995-07-06 1996-07-02 Neue thrombin-inhibitoren, deren herstellung und verwendung

Country Status (31)

Country Link
US (4) US6051568A (de)
EP (1) EP0836615B1 (de)
JP (1) JP4107682B2 (de)
KR (1) KR100435008B1 (de)
CN (1) CN1147504C (de)
AR (1) AR003440A1 (de)
AT (1) ATE238342T1 (de)
AU (1) AU709710B2 (de)
BR (1) BR9609447A (de)
CA (1) CA2226256C (de)
CZ (1) CZ298487B6 (de)
DE (1) DE69627659T2 (de)
DK (1) DK0836615T3 (de)
EE (1) EE04500B1 (de)
ES (1) ES2197240T3 (de)
HK (1) HK1008995A1 (de)
HU (1) HUP9802315A3 (de)
IL (1) IL122813A0 (de)
IS (1) IS2081B (de)
MX (1) MX9800146A (de)
MY (1) MY116539A (de)
NO (1) NO324092B1 (de)
NZ (2) NZ509474A (de)
PL (1) PL185606B1 (de)
PT (1) PT836615E (de)
RU (1) RU2176645C2 (de)
SA (1) SA96170106A (de)
SI (1) SI0836615T1 (de)
SK (1) SK284695B6 (de)
TR (1) TR199800009T1 (de)
WO (1) WO1997002284A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
SE9602263D0 (sv) 1996-06-07 1996-06-07 Astra Ab New amino acid derivatives
AU3496297A (en) * 1996-06-25 1998-01-14 Eli Lilly And Company Anticoagulant agents
US6200967B1 (en) 1996-06-25 2001-03-13 Eli Lilly And Company Anticoagulant agents
SE9602646D0 (sv) 1996-07-04 1996-07-04 Astra Ab Pharmaceutically-useful compounds
AR013084A1 (es) 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
SE9704543D0 (sv) 1997-12-05 1997-12-05 Astra Ab New compounds
JP2003529528A (ja) 1998-04-24 2003-10-07 ３−ディメンショナル ファーマシューティカルズ， インコーポレイテッド プロテアーゼインヒビターとしてのアミノ酸アミジノヒドラゾン、アルコキシグアニジン、およびアミノグアニジン
SE9802938D0 (sv) 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
AU1185400A (en) * 1998-11-20 2000-06-13 Banyu Pharmaceutical Co., Ltd. 1-acylazetidine derivatives
SE9804313D0 (sv) 1998-12-14 1998-12-14 Astra Ab New compounds
KR100639274B1 (ko) * 1999-01-13 2006-10-27 아스트라제네카 아베 신규 아미디노벤질아민 유도체 및 트롬빈 억제제로서의 용도
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
SE0001803D0 (sv) 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
ES2311538T3 (es) * 2000-08-16 2009-02-16 Astrazeneca Ab Nuevos derivados amidino y su uso como inhibidores de trombina.
US6433186B1 (en) * 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
SE0102921D0 (sv) * 2001-08-30 2001-08-30 Astrazeneca Ab Pharmaceutically useful compounds
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US7129233B2 (en) 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
US6528503B2 (en) * 2000-12-18 2003-03-04 Merck & Co., Inc. Thrombin inhibitors
CA2436176A1 (en) * 2001-02-09 2002-08-22 Merck & Co., Inc. Thrombin inhibitors
SE0101762D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab New use
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
UA78195C2 (uk) * 2001-08-30 2007-03-15 Astrazeneca Ab Похідні мигдалевої кислоти та їх застосування як інгібіторів тромбіну, фармацевтична композиція на їх основі
SE0201658D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201659D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
US7524354B2 (en) * 2005-07-07 2009-04-28 Research Foundation Of State University Of New York Controlled synthesis of highly monodispersed gold nanoparticles
TW200827336A (en) 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
HU192646B (en) * 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
ZA86746B (en) * 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
US5187157A (en) * 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0362002B1 (de) * 1988-09-01 1995-07-26 Merrell Dow Pharmaceuticals Inc. HIV Protease-Hemmer
ZA897514B (en) * 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
TW201303B (de) * 1990-07-05 1993-03-01 Hoffmann La Roche
CA2075154A1 (en) * 1991-08-06 1993-02-07 Neelakantan Balasubramanian Peptide aldehydes as antithrombotic agents
SE9102462D0 (sv) * 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
CZ333492A3 (en) * 1991-11-12 1993-09-15 Lilly Co Eli Dipeptide of l-azetidine-2-carboxylic acids and l-argininaldehyde, process of its preparation and pharmaceutical preparation in which said dipeptide is comprised
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
AU663169B2 (en) * 1992-03-04 1995-09-28 Gyogyszerkutato Intezet Kft New anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for the preparation thereof
TW223629B (de) 1992-03-06 1994-05-11 Hoffmann La Roche
US5519193A (en) 1992-10-27 1996-05-21 International Business Machines Corporation Method and apparatus for stressing, burning in and reducing leakage current of electronic devices using microwave radiation
AU675981B2 (en) * 1992-12-02 1997-02-27 Bristol-Myers Squibb Company Guanidinyl-substituted heterocyclic thrombin inhibitors
US5583146A (en) * 1992-12-02 1996-12-10 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US5780631A (en) * 1993-06-03 1998-07-14 Astra Aktiebolag Starting materials in the synthesis of thrombin and kininogenase inhibitors
DE4321444A1 (de) * 1993-06-28 1995-01-05 Bernd Prof Dr Clement Pharmazeutische Zubereitung
EP0648780A1 (de) * 1993-08-26 1995-04-19 Bristol-Myers Squibb Company Heterozyklische Thrombinhemmer
TW394760B (en) * 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
AU1025795A (en) * 1994-01-27 1995-08-03 Mitsubishi Chemical Corporation Prolineamide derivatives
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
ZA951617B (en) * 1994-03-04 1997-02-27 Lilly Co Eli Antithrombotic agents.
US5561146A (en) * 1994-06-10 1996-10-01 Bristol-Myers Squibb Company Modified guanidino and amidino thrombin inhibitors
DE4421052A1 (de) * 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
US5510369A (en) * 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
HUT77390A (hu) * 1994-11-24 1998-04-28 Janssen Pharmaceutica N.V. Lubeluzol intravénás oldatai és eljárás ezek előállítására
MX9706069A (es) * 1995-02-17 1997-10-31 Basf Ag Nuevos inhibidores de la trombina.
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5629324A (en) 1995-04-10 1997-05-13 Merck & Co., Inc. Thrombin inhibitors
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
SE9602263D0 (sv) * 1996-06-07 1996-06-07 Astra Ab New amino acid derivatives

Also Published As

Publication number Publication date
EP0836615A1 (de) 1998-04-22
CN1147504C (zh) 2004-04-28
IL122813A0 (en) 1998-08-16
EE9700354A (et) 1998-06-15
US20040087647A1 (en) 2004-05-06
SI0836615T1 (en) 2003-10-31
CZ421297A3 (cs) 1998-06-17
KR100435008B1 (ko) 2004-07-16
DE69627659T2 (de) 2004-03-04
PT836615E (pt) 2003-09-30
MX9800146A (es) 1998-03-31
ES2197240T3 (es) 2004-01-01
NO980015L (no) 1998-02-25
NZ311854A (en) 2000-06-23
PL185606B1 (pl) 2003-06-30
US20020042396A1 (en) 2002-04-11
CA2226256C (en) 2008-12-30
US6921758B2 (en) 2005-07-26
AU6325396A (en) 1997-02-05
US6051568A (en) 2000-04-18
DK0836615T3 (da) 2003-08-11
RU2176645C2 (ru) 2001-12-10
KR19990028755A (ko) 1999-04-15
AU709710B2 (en) 1999-09-02
NZ509474A (en) 2005-08-26
CA2226256A1 (en) 1997-01-23
HK1008995A1 (en) 1999-05-21
IS2081B (is) 2006-02-15
CN1195354A (zh) 1998-10-07
US6337343B1 (en) 2002-01-08
CZ298487B6 (cs) 2007-10-17
AR003440A1 (es) 1998-08-05
BR9609447A (pt) 1999-03-02
HUP9802315A2 (hu) 1999-01-28
JP4107682B2 (ja) 2008-06-25
US6617320B2 (en) 2003-09-09
TR199800009T1 (xx) 1998-05-21
NO980015D0 (no) 1998-01-02
SA96170106A (ar) 2005-12-03
WO1997002284A1 (en) 1997-01-23
EP0836615B1 (de) 2003-04-23
HUP9802315A3 (en) 1999-03-01
SK284695B6 (sk) 2005-09-08
SK180497A3 (en) 1998-11-04
NO324092B1 (no) 2007-08-13
EE04500B1 (et) 2005-06-15
PL324483A1 (en) 1998-05-25
IS4639A (is) 1997-12-22
JPH11508591A (ja) 1999-07-27
DE69627659D1 (de) 2003-05-28
MY116539A (en) 2004-02-28

Similar Documents

Publication Publication Date Title
ATE238342T1 (de) Neue thrombin-inhibitoren, deren herstellung und verwendung
PT1120392E (pt) Catalisador e composicao organometalica
DE59711847D1 (de) Substituierte aza- und diazacycloheptan- und -cyclooctanverbindungen und deren verwendung
DE69607321D1 (de) Reinigungsverfahren und zusammensetzung
ATE258549T1 (de) Oxazolidindion-derivate, ihre herstellung und verwendung
DE69700470T2 (de) Neue 19-nor-pregnen-derivate
ATE186447T1 (de) Zusammensetzung und verwendung
DE69620270T2 (de) Backfett und dessen Verwendung
DE69915066D1 (de) Biozide zusammensetzung und deren verwendung
DE69729570D1 (de) Fotpempfindliche zusammensetzung und deren verwendung
DE69632678D1 (de) Harzzusammensetzung und deren verwendung
DE69623844T2 (de) Beschichtungszusammensetzung und dessen Verwendung
DE69827144D1 (de) Neue blockpolymere und deren herstellung
DE69724629D1 (de) Zusammensetzungen und deren verwendungen
DE69620642T2 (de) Reiningungsverfahren und-zusammensetzung
ATE202782T1 (de) Optisch-aktives benzothiepin-derivate, ihre herstellung und verwendung
DE69607757T2 (de) Poröse materialbahn
TR199600371A2 (tr) Organosilan bilesiklerinin harmanlari ve bunlarin kullanimi.
BR9509688A (pt) Composto e composição farmacêutica
ATE252096T1 (de) Prolylendopeptidase-inhibitoren, ihre herstellung und ihre pharmazeutische verwendung
FI941914A (fi) 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö
DE69812256D1 (de) 7-propyl-benzodiosepin-3-one und dessen Verwendung in Parfümerie
DE69735015D1 (de) Neue Creatin-amidinohydrolase, ihre Herstellung und Verwendung
FI971317A (fi) Uusia heterosyklisiä, substituoituja imidatsolokinoksalinoneja, niiden valmistus ja käyttö
DE69631988D1 (de) Neue alkalische Phosphatase, deren Herstellung und Verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0836615

Country of ref document: EP

REN Ceased due to non-payment of the annual fee